A de novo convergence of autism genetics and molecular neuroscience

Niklas Krumm, Brian J. O'Roak, Jay Shendure, Evan E. Eichler

Research output: Contribution to journalReview article

258 Scopus citations

Abstract

Autism spectrum disorder (ASD) and intellectual disability (ID) are neurodevelopmental disorders with large genetic components, but identification of pathogenic genes has proceeded slowly because hundreds of loci are involved. New exome sequencing technology has identified novel rare variants and has found that sporadic cases of ASD/ID are enriched for disruptive de novo mutations. Targeted large-scale resequencing studies have confirmed the significance of specific loci, including chromodomain helicase DNA binding protein 8 (CHD8), sodium channel, voltage-gated, type II, alpha subunit (SCN2A), dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), and catenin (cadherin-associated protein), beta 1, 88. kDa (CTNNB1, beta-catenin). We review recent studies and suggest that they have led to a convergence on three functional pathways: (i) chromatin remodeling; (ii) wnt signaling during development; and (iii) synaptic function. These pathways and genes significantly expand the neurobiological targets for study, and suggest a path for future genetic and functional studies.

Original languageEnglish (US)
Pages (from-to)95-105
Number of pages11
JournalTrends in Neurosciences
Volume37
Issue number2
DOIs
StatePublished - Feb 2014

Keywords

  • Autism genetics
  • Autism spectrum disorder
  • Copy number variant
  • Exome sequencing
  • Intellectual disability
  • Single nucleotide variant

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'A de novo convergence of autism genetics and molecular neuroscience'. Together they form a unique fingerprint.

Cite this